0001730907-19-000005.txt : 20190619 0001730907-19-000005.hdr.sgml : 20190619 20190619131644 ACCESSION NUMBER: 0001730907-19-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190619 DATE AS OF CHANGE: 20190619 EFFECTIVENESS DATE: 20190619 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aclipse Therapeutics LLC CENTRAL INDEX KEY: 0001730907 IRS NUMBER: 823570666 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-342295 FILM NUMBER: 19905752 BUSINESS ADDRESS: STREET 1: 170 NORTH RADNOR CHESTER ROAD STREET 2: SUITE 350 CITY: RADNOR STATE: PA ZIP: 19087 BUSINESS PHONE: 412-606-7214 MAIL ADDRESS: STREET 1: 170 NORTH RADNOR CHESTER ROAD STREET 2: SUITE 350 CITY: RADNOR STATE: PA ZIP: 19087 FORMER COMPANY: FORMER CONFORMED NAME: Aclipse Therapeutics, LLC DATE OF NAME CHANGE: 20180209 D 1 primary_doc.xml X0708 D LIVE 0001730907 Aclipse Therapeutics LLC 170 NORTH RADNOR CHESTER ROAD SUITE 350 RADNOR PA PENNSYLVANIA 19087 412-606-7214 DELAWARE Aclipse Therapeutics, LLC Limited Liability Company true 2017 Raymond K Houck 5 Park Place, Suite 207 Annapolis MD MARYLAND 21401 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2019-06-08 true true Simple Agreement for Future Equity false 0 Indefinite 200000 Indefinite false 1 0 0 0 false Aclipse Therapeutics LLC /s/ Raymond K. Houck Raymond K. Houck President and CEO 2019-06-19